TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 191 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $749,000 | +72.2% | 9,959 | +9.2% | 0.00% | – |
| Q4 2021 | $435,000 | -37.7% | 9,121 | -13.2% | 0.00% | – |
| Q3 2021 | $698,000 | -0.3% | 10,513 | +17.2% | 0.00% | – |
| Q2 2021 | $700,000 | -20.0% | 8,968 | -3.1% | 0.00% | – |
| Q1 2021 | $875,000 | -68.6% | 9,255 | -59.5% | 0.00% | -100.0% |
| Q4 2020 | $2,788,000 | +157.7% | 22,880 | +84.7% | 0.00% | 0.0% |
| Q3 2020 | $1,082,000 | +225.9% | 12,389 | +141.6% | 0.00% | – |
| Q2 2020 | $332,000 | -20.2% | 5,127 | -23.2% | 0.00% | -100.0% |
| Q4 2019 | $416,000 | – | 6,674 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |